Educational and Informational Intervention for Advanced Cancer Parents

(EC-PC Trial)

No longer recruiting at 6 trial locations
EH
Overseen ByEllen H Zahlis
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Washington
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial evaluates two educational programs designed to help parents with advanced cancer strengthen relationships with their children and boost confidence in discussing their illness. One program involves a booklet and phone support, while the other includes a more in-depth, five-session series with a patient educator. The goal is to reduce anxiety and depression and improve well-being for both parents and their children. Ideal participants are parents with late-stage cancer and a child aged 5 to 17 living at home. As an unphased trial, this study offers a unique opportunity for parents to gain valuable support and resources tailored to their needs.

Do I need to stop my current medications to join the trial?

The trial does not specify whether you need to stop taking your current medications. All therapies are allowed, so you likely can continue your current treatment.

What prior data suggests that these educational programs are safe for parents with advanced cancer?

Previous studies have shown that educational programs like patient navigation are very safe. These programs support cancer patients by providing information and have successfully improved access to care and outcomes without known risks.

Research on the Enhancing Connections Program also shows it is well-tolerated. This program helps parents with cancer communicate better with their children. Studies have shown it can reduce stress and improve well-being, with no reports of harm or negative effects.

Overall, both educational programs and the Enhancing Connections Program are considered safe. They help parents manage the impact of cancer on their family without introducing new health risks.12345

Why are researchers excited about this trial?

Researchers are excited about these interventions because they offer new ways to support parents with advanced cancer in communicating with their children. Unlike standard psychological support, which often focuses on the patient's mental health, these programs specifically target family communication. The Educational Intervention provides parents with carefully curated materials and counselor support to improve conversations about cancer. Meanwhile, the Enhancing Connections Program offers a structured, five-session approach to equip parents with strategies to support their children emotionally. These interventions aim to strengthen family bonds during a challenging time, potentially leading to better emotional outcomes for both parents and children.

What evidence suggests that these educational programs are effective for parents with advanced cancer?

Research shows that educational programs can greatly assist parents with advanced cancer. In this trial, participants in Group II will receive educational materials, including a carefully selected booklet and a scripted phone call from a trained counselor, to help them discuss their cancer with their child. Studies have found that patient navigation programs, part of these educational efforts, reduce caregiver stress by providing better education and emotional support. As a result, parents may feel more confident in managing their illness and talking to their children.

Participants in Group I will receive the Enhancing Connections Program, which also shows promise. This program includes a 5-session bi-weekly intervention with a patient educator, helping parents improve their skills and confidence in discussing cancer with their children, which can strengthen their relationship. Additionally, these programs may lower anxiety and depression, enhancing the well-being and quality of life for both parents and their children.12367

Who Is on the Research Team?

FM

Frances M Lewis, RN, MN, PhD, FAAN

Principal Investigator

University of Washington

Are You a Good Fit for This Trial?

This trial is for parents aged 23-68 with advanced, non-curable cancer who have a child between the ages of 5 and 17 living at home at least half the time. Participants must be able to read/write English, not be in hospice care, and have access to a phone. The non-ill co-parent must consent to participate.

Inclusion Criteria

Read and write English as one of their languages of choice
Ability to understand and the willingness to sign a written informed consent document. Read and write English as one of their languages of choice
I am a parent with late-stage cancer that cannot be cured.
See 4 more

Exclusion Criteria

Patient is in hospice at time of enrollment
Non-ill co-parent does not consent to join study

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either the 5-session EC-PC program bi-weekly or educational materials with a phone call

10 weeks
5 sessions (in-person or virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment

3 months

Long-term Follow-up

Effects of family environment and symptom burden on treatment outcomes are assessed

Up to 10 months

What Are the Treatments Tested in This Trial?

Interventions

  • Control group
  • Educational Intervention
  • Enhancing Connections Program
  • Informational Intervention
  • Questionnaire Administration
Trial Overview The study tests two educational programs aimed at improving quality of life and parenting confidence for those with late-stage cancer. It focuses on enhancing parent-child relationships and managing the impact of cancer on children.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (enhancing connections-palliative care program)Experimental Treatment2 Interventions
Group II: Group II (educational material)Active Control2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Washington

Lead Sponsor

Trials
1,858
Recruited
2,023,000+

National Institute of Nursing Research (NINR)

Collaborator

Trials
623
Recruited
10,400,000+

Published Research Related to This Trial

Parents of children with cancer actively participated in a study to identify risks associated with home oral chemotherapy, revealing high rates of potential errors, particularly due to miscommunication and unsafe handling of medications.
The study proposed innovative risk reduction strategies, including the use of technology to enhance communication and access to information, aimed at improving the safety of home chemotherapy administration.
Multisite parent-centered risk assessment to reduce pediatric oral chemotherapy errors.Walsh, KE., Mazor, KM., Roblin, D., et al.[2022]
A survey of 1243 oncology certified nurses revealed that they frequently counsel patients on lifestyle topics during chemotherapy, such as hydration, infection monitoring, and exercise, despite the lack of standardized evidence-based guidelines.
Nurses' counseling practices are influenced by their institutions and colleagues, indicating a need for expert consensus guidelines to improve and standardize patient education on lifestyle issues during chemotherapy.
Chemotherapy education: current practices of oncology nurses counseling patients.Rogers, B., Pesata, B., Lee, JH., et al.[2021]
A qualitative study involving 14 parents of children with cancer and 8 healthcare providers in Malaysia identified three key themes of information needs: interaction with the healthcare system, care for the child at home, and psychosocial support for parents.
Addressing these information needs is crucial for enhancing psychosocial care, as it empowers parents in their caregiving roles and highlights the necessity for tailored informational resources from healthcare providers.
Information needs of Malaysian parents of children with cancer: A qualitative study.Tan, CE., Lau, SCD., Latiff, ZA., et al.[2022]

Citations

Patient Navigator PRE-ACT Educational Intervention to ...The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome ...
Patient Navigation in Cancer Treatment: A Systematic ReviewThis systematic review provides compelling evidence supporting the value of patient navigation programs in cancer treatment.
Patient navigation across the cancer care continuum: An ...Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella ...
(PDF) Effectiveness of Cancer Patient Navigator Program ...The results also showed that patient navigator programs can significantly reduce caregiver burden through improved education, emotional support, ...
Impact of Virtual Navigation on the Education and Access ...This study explores a unique role that virtual navigation may play in helping accommodate healthcare for many cancer patients in underserved areas.
study protocol for the EU NAVIGATE International Pragmatic ...Cancer navigation programs aim to support, educate, and empower patients and families, addressing barriers to diagnostics, treatment, ...
Enhancing Connections-Palliative Care: A Quasi ...In 2018, an estimated 381,777 children were impacted by a new diagnosis of cancer in a parent, and an estimated 20% of parents were diagnosed with advanced ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security